top 10 digital money- Top Knowledge

How to "bargain" the price difference of Chinese patent medicines? According to CCTV news, the National Medical Insurance Bureau responded that the price of proprietary Chinese medicines is affected by many factors, including the price of medicinal materials, production technology and brand value, in view of the large price difference of proprietary Chinese medicines and the problem of "bargaining". Centralized purchasing effectively squeezes the inflated price of drugs and improves the efficiency of capital use through market-oriented bidding and price-volume linkage. At the same time, the medical insurance bureau will strengthen monitoring and supervision to ensure the quality and supply of drugs and protect the rights and interests of patients.Six countries' chemical companies set up resource recycling companies, including new material technology research and development business. According to the enterprise survey APP, Hubei Xingyang Resource Recycling Co., Ltd. was recently established, with the legal representative of Xu Jinchong and the registered capital of about 145 million yuan. Its business scope includes: new material technology research and development; Manufacturing of eco-environmental materials; Sales of eco-environmental materials; Lime and gypsum manufacturing; Manufacturing of light building materials; Environmental consulting services; Processing of renewable resources, etc. Enterprise equity penetration shows that the company is jointly owned by Hubei Huiyang New Materials Co., Ltd. and dangyang city Jiantou Asset Management Co., Ltd., a subsidiary of Liuguo Chemical.Argentine President Millay: Negotiations on a free trade agreement with the Trump administration will be launched next year. Argentine President Millay said in a national televised speech on December 10 local time that he plans to negotiate a free trade agreement with the newly appointed Trump administration of the United States next year, and promised to make Argentina more independent from MERCOSUR. After the historic trade agreement between MERCOSUR and the European Union last week, he criticized that MERCOSUR has become a "prison" for member States. "Our ultimate goal in MERCOSUR is to improve the autonomy of the members of this group to the rest of the world." Millay said, "In this spirit, our primary goal will be to start a free trade agreement with the United States next year." He also mentioned on the same day that Argentina plans to cancel capital controls next year.

Treasury futures collectively opened lower, with 30-year main contracts down 0.38%, 30-year main contracts down 0.38%, 10-year main contracts down 0.11%, 5-year main contracts down 0.06% and 2-year main contracts down 0.04%.Yesterday, a total of 48 stock ETFs increased by over 100 million shares, the Southern CSI 1000ETF increased by 1.366 billion shares, and the Huaxia CSI A500ETF increased by 1.35 billion shares.Low-priced stocks fluctuated strongly, with Shan Ying International, Palm, Xiamen Industrial Co., Huaying Agriculture, Smith Barney, Pubang, Yabo and Jishi Media trading daily.

The insurance sector fell by more than 8% in the short term, and the insurance sector fell by more than 8% in the short term. New China Life Insurance, China PICC, China Life Insurance and China Pacific Insurance followed suit.How to "bargain" the price difference of Chinese patent medicines? According to CCTV news, the National Medical Insurance Bureau responded that the price of proprietary Chinese medicines is affected by many factors, including the price of medicinal materials, production technology and brand value, in view of the large price difference of proprietary Chinese medicines and the problem of "bargaining". Centralized purchasing effectively squeezes the inflated price of drugs and improves the efficiency of capital use through market-oriented bidding and price-volume linkage. At the same time, the medical insurance bureau will strengthen monitoring and supervision to ensure the quality and supply of drugs and protect the rights and interests of patients.The first day of listing, the new shares of Gem Boyuan opened sharply higher, and now it has risen by over 220%.